Effects of neonatal axoplasmic transport attenuation on the response properties of vibrissae-sensitive neurons in the trigeminal principal sensory nucleus of the rat.
We have previously shown that attenuation of axoplasmic transport by application of vinblastine to the developing infraorbital nerve (ION) results in a loss of central vibrissae-related patterns that is not accompanied by changes in the receptive field sizes for the V primary afferents innervating the whisker follicles. The present study examines the relationship between the loss of central vibrissae-related patterns and alterations in the response properties of neurons in the V principal sensory nucleus (PrV) of adult rats that sustained application of vinblastine to the ION at birth. Absence of histochemically demonstrable vibrissae-related patterns in PrV resulted in only modest changes in the receptive fields and response properties of vibrissae-sensitive neurons in this nucleus that projected to the contralateral thalamus. Response latencies to electrical activation of the V ganglion were similar in treated and untreated animals. The mean receptive field size was significantly increased from 1.3 +/- 0.7 vibrissae in controls to 1.7 +/- 0.9 vibrissae in vinblastine-treated animals, and the percentage of cells yielding a tonic response to vibrissae deflection was markedly reduced (p < 0.01 for both measures). Phasically responding cells recorded in vinblastine-treated animals showed a significant reduction in the mean number of spikes per stimulus following deflection of the vibrissae in either the preferred or non-preferred direction relative to cells recorded in normal animals (p < 0.05). The present results indicate that disruption of the normal vibrissae-related aggregates of neurons in PrV by application of vinblastine to the ION has limited effects on the functional representation of the vibrissae in this nucleus.
Chiaia
N L
NL
Department of Anatomy and Neurobiology, Medical College of Ohio, Toledo 43614-5804, USA.
Zhang
S
S
Crissman
R S
RS
Rhoades
R W
RW
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D000831:Animals, Newborn; D000972:Antineoplastic Agents, Phytogenic; D001370:Axonal Transport / Q000502:physiology*; D003714:Denervation; D004594:Electrophysiology; D009475:Neurons, Afferent / Q000502:physiology*; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000502:physiology; D014110:Touch / Q000502:physiology; D014278:Trigeminal Nuclei / Q000166:cytology / Q000502:physiology*; D014738:Vibrissae / Q000294:innervation* / Q000502:physiology; D014750:Vincristine
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine